Compare GEMI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEMI | CTKB |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | 650 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.3M | 541.1M |
| IPO Year | N/A | 2021 |
| Metric | GEMI | CTKB |
|---|---|---|
| Price | $4.16 | $4.31 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | ★ $8.31 | $5.63 |
| AVG Volume (30 Days) | 1.7M | ★ 2.0M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $35.05 | $5.42 |
| Revenue Next Year | $39.56 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $3.91 | $3.09 |
| 52 Week High | $34.67 | $6.18 |
| Indicator | GEMI | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 56.14 |
| Support Level | $4.05 | $4.13 |
| Resistance Level | $5.24 | $4.49 |
| Average True Range (ATR) | 0.40 | 0.24 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 4.73 | 76.67 |
Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.